Vertex reached an agreement on Sunday to sell its newest cystic fibrosis drug in Australia, ending a high-profile standoff over access to a life-altering but expensive rare disease drug.
As with most agreements between drugmakers and national payment systems, Vertex and the Australian Pharmaceutical Benefits Scheme didn’t say how much....
